610 filings
Page 7 of 31
4
Crispin Teufel
4 Jan 22
Bellerophon Therapeutics / Crispin Teufel ownership change
4:10pm
4
BLPH
Bellerophon Therapeutics, Inc.
4 Jan 22
Bellerophon Therapeutics / Scott P Bruder ownership change
4:10pm
4
Naseem Amin
4 Jan 22
Bellerophon Therapeutics / Naseem Amin ownership change
4:10pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
17 Dec 21
Phase 2 results provide clinically meaningful reduction in pulmonary vascular resistance; Company intends to design multi-dose Phase 2b trial
8:29am
8-K
BLPH
Bellerophon Therapeutics, Inc.
15 Nov 21
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2021 Financial Results
9:02am
10-Q
2021 Q3
BLPH
Bellerophon Therapeutics, Inc.
Quarterly report
15 Nov 21
8:30am
8-K
BLPH
Bellerophon Therapeutics, Inc.
12 Nov 21
Departure of Directors or Certain Officers
8:24am
8-K
BLPH
Bellerophon Therapeutics, Inc.
12 Oct 21
Departure of Directors or Certain Officers
4:59pm
3
BLPH
Bellerophon Therapeutics, Inc.
8 Oct 21
Bellerophon Therapeutics / Nicholas Laccona ownership change
5:26pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
6 Oct 21
Departure of Directors or Certain Officers
8:58am
8-K
BLPH
Bellerophon Therapeutics, Inc.
31 Aug 21
Departure of Directors or Certain Officers
5:00pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
5 Aug 21
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2021 Financial Results
8:29am
8-K/A
BLPH
Bellerophon Therapeutics, Inc.
11 Jun 21
Submission of Matters to a Vote of Security Holders
8:36am
S-8
BLPH
Bellerophon Therapeutics, Inc.
11 Jun 21
Registration of securities for employees
8:31am
4
Puissance Life Science Opportunities Fund VI
8 Jun 21
Bellerophon Therapeutics / Theodore T Wang ownership change
12:37pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
26 May 21
Bellerophon Appoints Naseem Amin, M.D. as Chairman of its Board of Directors
4:05pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
11 May 21
Bellerophon Provides Clinical Program Update and Reports First Quarter 2021 Financial Results
8:36am
10-Q
2021 Q1
BLPH
Bellerophon Therapeutics, Inc.
Quarterly report
11 May 21
8:30am
SC 13D/A
Puissance Life Science Opportunities Fund VI
27 Apr 21
Bellerophon Therapeutics / Puissance Life Science Opportunities Fund VI ownership change
9:45pm